Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells

Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression

(2014) Silvia Niesporek et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

The impact of chemokine receptor CXCR4 on breast cancer prognosis: A meta-analysis

(2013) Tong-peng Xu et al.   Cancer Epidemiology

miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer

(2013) Wijdan Al-Ahmadi et al.   JOURNAL OF PATHOLOGY

Halting metastasis through CXCR4 inhibition

(2012) Deborah M. Ramsey et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State

(2012) Robert J. Rounbehler et al.   CELL

A review on CXCR4/CXCL12 axis in oncology: No place to hide

(2012) Urszula M. Domanska et al.   EUROPEAN JOURNAL OF CANCER

Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival

(2012) Rohit Upadhyay et al.   INTERNATIONAL JOURNAL OF CANCER

The role of CXC chemokines and their receptors in the progression and treatment of tumors

(2012) Qingchao Zhu et al.   JOURNAL OF MOLECULAR HISTOLOGY

The p38/MK2-Driven Exchange between Tristetraprolin and HuR Regulates AU–Rich Element–Dependent Translation

(2012) Christopher Tiedje et al.   PLoS Genetics

Sequence variations affecting AU-rich element function and disease

(2011) Edward Hitti   Frontiers in Bioscience-Landmark

A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients

(2011) Paola Griseri et al.   HUMAN MOLECULAR GENETICS

AU-Rich-Element-Dependent Translation Repression Requires the Cooperation of Tristetraprolin and RCK/P54

(2011) M.-Y. Qi et al.   MOLECULAR AND CELLULAR BIOLOGY

A Synthetic Biology Approach Reveals a CXCR4-G13-Rho Signaling Axis Driving Transendothelial Migration of Metastatic Breast Cancer Cells

(2011) H. Yagi et al.   Science Signaling

Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements

(2010) Khalid S. A. Khabar   CELLULAR AND MOLECULAR LIFE SCIENCES

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model

(2010) Saima Hassan et al.   INTERNATIONAL JOURNAL OF CANCER

The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes

(2010) N Al-Souhibani et al.   ONCOGENE

A versatile ribosomal protein promoter-based reporter system for selective assessment of RNA stability and post-transcriptional control

(2010) E. Hitti et al.   RNA

The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient Prognosis

(2009) S. E. Brennan et al.   CANCER RESEARCH

The mRNA Binding Proteins HuR and Tristetraprolin Regulate Cyclooxygenase 2 Expression During Colon Carcinogenesis

(2009) Lisa E. Young et al.   GASTROENTEROLOGY

Functional Switching of TGF-β1 Signaling in Liver Cancer via Epigenetic Modulation of a Single CpG Site in TTP Promoter

(2009) Bo Hwa Sohn et al.   GASTROENTEROLOGY

Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation

(2009) Wijdan Al-Ahmadi et al.   NUCLEIC ACIDS RESEARCH